2025 HCPCS Code C7501
Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)
TAGS: lesion lesions appropriate placement metallic imaging percutaneous unilateral breast biopsy single stereotactic biopsies bilateral using localization| Short Description | Perc bx breast lesions stero |
| Product Note | 0229 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2023 |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Pricing Indicator Code | 11 - Price established using national rvu's |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9451 - Injection, peramivir
- C9452 - Inj, ceftolozane/tazobactam
- C9453 - Injection, nivolumab
- C9454 - Inj, pasireotide long acting
- C9455 - Injection, siltuximab
- C9456 - Inj, isavuconazonium sulfate
- C9457 - Lumason contrast agent
- C9458 - Florbetaben f18
- C9459 - Flutemetamol f18
- C9460 - Injection, cangrelor
- C9461 - Choline c 11, diagnostic
- C9462 - Injection, delafloxacin
- C9463 - Injection, aprepitant
- C9464 - Injection, rolapitant
- C9465 - Injection, durolane
- C9466 - Injection, benralizumab
- C9467 - Inj rituximab hyaluronidase
- C9468 - Inj, factor ix, rebinyn
- C9469 - Inj triamcinolone acetonide
- C9470 - Aripiprazole lauroxil im
